Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease

World Journal of Gastroenterology

Volumn 19, Issue 1, 2013, Pages 17-25

  Garrido, Elena ^a   Carrera, Elisa ^b   Manzano, Rebeca ^c   Lopez Sanroman, Antonio ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^c Hospital del Sureste   (Spain)

Author keywords

Crohn's disease; Cytomegalovirus; Ganciclovir; Hematoxylin and eosin; Immunohistochemical; Infectious colitis; Inflammatory bowel disease; Polymerase chain reaction; Ulcerative colitis

Indexed keywords

CIDOFOVIR; CYTOMEGALOVIRUS ANTIGEN PP65; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VALGANCICLOVIR; VIRUS DNA;

ARTICLE; BONE MARROW SUPPRESSION; COLITIS; COLON BIOPSY; COLON RESECTION; CROHN DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENDOSCOPY; ENTERITIS; FEVER; HEADACHE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYPERTRANSAMINASEMIA; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; NEPHROTOXICITY; NEUTROPENIA; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; PSYCHOSIS; RASH; RECOMMENDED DRUG DOSE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SOMNOLENCE; ULCERATIVE COLITIS; VIRUS CULTURE; VIRUS REACTIVATION;

EID: 84873641003     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i1.17     Document Type: Article

References (108)

1. Alford CA, Stagno S, Pass RF, Britt WJ. Congenital and perinatal cytomegalovirus infections. Rev Infect Dis 1993; 12 Suppl 7: S745-S753 [PMID: 2173104 DOI: 10.1093/clinids/12.Supplement_7.S745]
2. Nelson MR, Erskine D, Hawkins DA, Gazzard BG. Treatment with corticosteroids--a risk factor for the development of clinical cytomegalovirus disease in AIDS. AIDS 1993; 7: 375-378 [PMID: 8097096 DOI: d10.1097/00002030-199303000-00011]
3. Ayre K, Warren BF, Jeffery K, Travis SP. The role of CMV in steroid-resistant ulcerative colitis: A systematic review. J Crohns Colitis 2009; 3: 141-148 [PMID: 21172262 DOI: 10.1016/j.crohns.2009.03.002]
4. Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ 1973; 49: 103-106 [PMID: 4363395]
5. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43: 1143-1151 [PMID: 17029132 DOI: 10.1086/508173]
6. Zhang LJ, Hanff P, Rutherford C, Churchill WH, Crumpacker CS. Detection of human cytomegalovirus DNA, RNA, and antibody in normal donor blood. J Infect Dis 1995; 171: 1002-1006 [PMID: 7706776 DOI: 10.1093/infdis/171.4.1002]
7. Colugnati FA, Staras SA, Dollard SC, Cannon MJ. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007; 7: 71 [PMID: 17605813 DOI: 10.1186/1471-2334-7-71]
8. Mcgavran MH, Smith MG. Ultrastructural, cytochemical, and microchemical observations on cytomegalovirus (salivary gland virus) infection of human cells in tissue culture. Exp Mol Pathol 1965; 76: 1-10 [PMID: 14297550 DOI: 10.1016/0014-4800(65)90019-5]
9. Pass RF. Epidemiology and transmission of cytomegalovirus. J Infect Dis 1985; 152: 243-248 [PMID: 2993429 DOI: 10.1093/infdis/152.2.243]
10. de la Hoz RE, Stephens G, Sherlock C. Diagnosis and treatment approaches of CMV infections in adult patients. J Clin Virol 2002; 25 Suppl 2: S1-12 [PMID: 12361752 DOI: 10.1016/S1386-6532(02)00091-4]
11. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev 2009; 22: 76-98 [PMID: 19136435 DOI: 10.1128/CMR.00034-08]
12. Grefte A, van der Giessen M, van Son W, The TH. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J Infect Dis 1993; 167: 270-277 [PMID: 8380609 DOI: 10.1093/infdis/167.2.270]
13. Jacobson MA, Mills J. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment. Ann Intern Med 1988; 108: 585-594 [PMID: 2831765 DOI: 10.7326/0003-4819-108-4-585]
14. Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 1998; 177: 1182-1187 [PMID: 9593001 DOI: 10.1086/515281]
15. Ho M. Virus infections after transplantation in man. Brief review. Arch Virol 1977; 55: 1-24 [PMID: 200197 DOI: 10.1007/BF01314475]
16. Van der Giessen M, van den Berg AP, van der Bij W, Postma S, van Son WJ, The TH. Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection. Clin Exp Immunol 1990; 80: 56-61 [PMID: 2157567 DOI: 10.1111/j.1365-2249.1990.tb06441.x]
17. Revello MG, Zavattoni M, Furione M, Lilleri D, Gorini G, Gerna G. Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. J Infect Dis 2002; 186: 553-557 [PMID: 12195384 DOI:10.1086/341831]
18. Nagington J. Cytomegalovirus antibody production in renal transplant patients. J Hyg (Lond) 1971; 69: 645-660 [PMID: 4332511 DOI: 10.1017/S0022172400021926]
19. Rawlinson WD. Broadsheet. Number 50: Diagnosis of human cytomegalovirus infection and disease. Pathology 1999; 31: 109-115 [PMID: 10399165 DOI: 10.1080/003130299105287]
20. Moonka D, Furth EE, MacDermott RP, Lichtenstein GR. Pouchitis associated with primary cytomegalovirus infection. Am J Gastroenterol 1998; 93: 264-266 [PMID: 9468256 DOI: 10.1016/S0002-9270(97)00068-3]
21. Casadesus D, Tani T, Wakai T, Maruyama S, Iiai T, Okamoto H, Hatakeyama K. Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouchanal anastomosis in patients with ulcerative colitis. World J Gastroenterol 2007; 13: 1085-1089 [PMID: 17373744 DOI:1007-9327/13/1085.asp]
22. Muñoz-Juarez M, Pemberton JH, Sandborn WJ, Tremaine WJ, Dozois RR. Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two cases. Dis Colon Rectum 1999; 42: 117-120 [PMID: 10211531 DOI: 10.1007/BF02235196]
23. Criscuoli V, Rizzuto MR, Cottone M. Cytomegalovirus and inflammatory bowel disease: is there a link? World J Gastroenterol 2006; 12: 4813-4818 [PMID: 16937462 DOI: 1007-9327/12/4813.asp]
24. Criscuoli V, Rizzuto MR, Montalbano L, Gallo E, Cottone M. Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis. World J Gastroenterol 2011; 17: 633-638 [PMID: 21350712 DOI:10.3748/wjg.v17.i5.633]
25. Galiatsatos P, Shrier I, Lamoureux E, Szilagyi A. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci 2005; 50: 609-616 [PMID: 15844689 DOI: 10.1007/s10620-005-2544-6]
26. Ng FH, Chau TN, Cheung TC, Kng C, Wong SY, Ng WF, Lee KC, Chan E, Lai ST, Yuen WC, Chang CM. Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci 1999; 44: 945-952 [PMID: 10235602]
27. Kim CH, Bahng S, Kang KJ, Ku BH, Jo YC, Kim JY, Chang DK, Son HJ, Rhee PL, Kim JJ, Rhee JC, Kim YH. Cytomegalovirus colitis in patients without inflammatory bowel disease: a single center study. Scand J Gastroenterol 2010; 45: 1295-1301 [PMID: 20568970]
28. Powell RD, Warner NE, Levine RS, Kirsner JB. Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult. Am J Med 1961; 30: 334-340 [PMID: 13737621 DOI: 10.1016/0002-9343(61)90105-X]
29. Wakefield AJ, Fox JD, Sawyerr AM, Taylor JE, Sweenie CH, Smith M, Emery VC, Hudson M, Tedder RS, Pounder RE. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 1992; 38: 183-190 [PMID: 1287131 DOI: 10.1002/jmv.1890380306]
30. Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis 2010; 16: 1620-1627 [PMID: 20232408 DOI: 10.1002/ibd.21275]
31. Domènech E, Vega R, Ojanguren I, Hernández A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabré E, Gassull MA. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 2008; 14: 1373-1379 [PMID:18452205 DOI: 10.1002/ibd.20498]
32. Boivin G, Handfield J, Toma E, Murray G, Lalonde R, Tevere VJ, Sun R, Bergeron MG. Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects. J Clin Microbiol 1998; 36: 2509-2513 [PMID: 9705384]
33. Lazzarotto T, Dal Monte P, Landini MP. Recent advances in the diagnosis of cytomegalovirus infection. Ann Biol Clin (Paris) 1996; 54: 259-265 [PMID: 8949423 DOI: 10.1016/j.humimm.2004.02.006]
34. Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, Okamoto S, Morohoshi Y, Izumiya M, Ichikawa H, Sato T, Inoue N, Ogata H, Hibi T. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007; 102: 331-337 [PMID: 17156136 DOI: 10.1111/j.1572-0241.2006.00989.x]
35. Nakase H, Matsumura K, Yoshino T, Chiba T. Systematic review: cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 2008; 43: 735-740 [PMID: 18958541 DOI: 10.1007/s00535-008-2246-x]
36. Michaelides A, Liolios L, Glare EM, Spelman DW, Bailey MJ, Walters EH, Williams TJ, Snell GI, Kotsimbos TC. Increased human cytomegalovirus (HCMV) DNA load in peripheral blood leukocytes after lung transplantation correlates with HCMV pneumonitis. Transplantation 2001; 72: 141-147 [PMID: 11468549]
37. Rowshani AT, Bemelman FJ, van Leeuwen EM, van Lier RA, ten Berge IJ. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation 2005; 79: 381-386 [PMID: 15729162 DOI:10.1097/01.TP.0000148239.00384.F0]
38. Gerna G, Lilleri D. Monitoring transplant patients for human cytomegalovirus: Diagnostic update. Herpes 2006; 13: 4-11 [PMID: 16732996 DOI: 10.1111/j.1600-6143.2006.01488.x]
39. Roberts TC, Brennan DC, Buller RS, Gaudreault-Keener M, Schnitzler MA, Sternhell KE, Garlock KA, Singer GG, Storch GA. Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients. J Infect Dis 1998; 178: 626-635 [PMID: 9728529 DOI: 10.1086/515383]
40. Einsele H, Ehninger G, Steidle M, Vallbracht A, Müller M, Schmidt H, Saal JG, Waller HD, Müller CA. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet 1991; 338: 1170-1172 [PMID: 1682592 DOI: 10.1016/0140-6736(91)92032-W]
41. Cottone M, Pietrosi G, Martorana G, Casà A, Pecoraro G, Oliva L, Orlando A, Rosselli M, Rizzo A, Pagliaro L. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001; 96: 773-775 [PMID: 11280549 DOI: 10.1016/S0002-9270(00)02413-8]
42. Criscuoli V, Casà A, Orlando A, Pecoraro G, Oliva L, Traina M, Rizzo A, Cottone M. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis 2004; 36: 818-820 [PMID: 15646428 DOI: 10.1016/j.dld.2004.05.013]
43. Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, Matsuura M, Ohmori K, Sakurai T, Nagayama S, Hasegawa S, Sakai Y, Chiba T. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2007; 13: 1516-1521 [PMID: 17828781 DOI: 10.1002/ibd.20253]
44. Boom R, Sol C, Weel J, Lettinga K, Gerrits Y, van Breda A, Wertheim-Van Dillen P. Detection and quantitation of human cytomegalovirus DNA in faeces. J Virol Methods 2000; 84: 1-14 [PMID: 10644082 DOI: 10.1016/S0166-0934(99)00127-5]
45. Michel D, Marre E, Hampl W, Roczkos J, Müller S, Hertenstein B, Kern P, Heymer B, Salzberger B, Arasteh K. Intestinal cytomegalovirus disease in immunocompromised patients may be ruled out by search for cytomegalovirus DNA in stool samples. J Clin Microbiol 1995; 33: 3064-3067 [PMID: 8576379]
46. Wu GD, Shintaku IP, Chien K, Geller SA. A comparison of routine light microscopy, immunohistochemistry, and in situ hybridization for the detection of cytomegalovirus in gastrointestinal biopsies. Am J Gastroenterol 1989; 84:1517-1520 [PMID: 2556912]
47. Cotte L, Drouet E, Bissuel F, Denoyel GA, Trepo C. Diagnostic value of amplification of human cytomegalovirus DNA from gastrointestinal biopsies from human immunodeficiency virus-infected patients. J Clin Microbiol 1993; 31: 2066-2069 [PMID: 8396587]
48. Dieterich DT, Rahmin M. Cytomegalovirus colitis in AIDS: presentation in 44 patients and a review of the literature. J Acquir Immune Defic Syndr 1991; 4 Suppl 1: S29-S35 [PMID: 1848619]
49. Franzin G, Muolo A, Griminelli T. Cytomegalovirus inclusions in the gastroduodenal mucosa of patients after renal transplantation. Gut 1981; 22: 698-701 [PMID: 6271652 DOI: 10.1136/gut.22.9.698]
50. Beaugerie L, Cywiner-Golenzer C, Monfort L, Girard PM, Carbonnel F, Ngô Y, Cosnes J, Rozenbaum W, Nicolas JC, Châtelet FP, Gendre JP. Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 423-429 [PMID: 9170416 DOI: 10.1097/00042560-199704150-00005]
51. Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006; 101: 2857-2865 [PMID: 17026558 DOI: 10.1111/j.1572-0241.2006.00869.x]
52. Rahbar A, Boström L, Lagerstedt U, Magnusson I, Söderberg-Naucler C, Sundqvist VA. Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis 2003; 9: 154-161 [PMID: 12792220 DOI: 10.1097/00054725-200305000-00002]
53. Robey SS, Gage WR, Kuhajda FP. Comparison of immunoperoxidase and DNA in situ hybridization techniques in the diagnosis of cytomegalovirus colitis. Am J Clin Pathol 1988; 89: 666-671 [PMID: 2833851]
54. Roblin X, Pillet S, Oussalah A, Berthelot P, Del Tedesco E, Phelip JM, Chambonnière ML, Garraud O, Peyrin-Biroulet L, Pozzetto B. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol 2011; 106: 2001-2008 [PMID: 21788989 DOI: 10.1038/ajg.2011.202]
55. Kou T, Nakase H, Tamaki H, Kudo T, Nishio A, Chiba T. Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis. Dig Dis Sci 2006; 51: 1052-1055 [PMID: 16865568 DOI: 10.1007/s10620-006-8006-y]
56. Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 879-884 [PMID: 16954807 DOI:10.1097/01.mib.0000231576.11678.57]
57. Landry ML, Ferguson D. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J Clin Microbiol 1993; 31: 2851-2856 [PMID: 8263166]
58. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002; 34: 1094-1097 [PMID: 11914998 DOI:10.1086/339329]
59. Sakamoto I, Shirai T, Kamide T, Igarashi M, Koike J, Ito A, Takagi A, Miwa T, Kajiwara H. Cytomegalovirus enterocolitis in an immunocompetent individual. J Clin Gastroenterol 2002; 34: 243-246 [PMID: 11873105 DOI: 10.1097/00004836-200203000-00010]
60. Wada Y, Matsui T, Matake H, Sakurai T, Yamamoto J, Kikuchi Y, Yorioka M, Tsuda S, Yao T, Yao S, Haraoka S, Iwashita A. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum 2003; 46: S59-S65 [PMID:14530660 DOI: 10.1097/01.DCR.0000087486.21981.C6]
61. Suzuki H, Kato J, Kuriyama M, Hiraoka S, Kuwaki K, Yamamoto K. Specific endoscopic features of ulcerative colitis complicated by cytomegalovirus infection. World J Gastroenterol 2010; 16: 1245-1251 [PMID: 20222169 DOI: 10.3748/wjg.v16.i10.1245]
62. Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, Domènech E, Eliakim R, Eser A, Frater J, Gassull M, Giladi M, Kaser A, Lémann M, Moreels T, Moschen A, Pollok R, Reinisch W, Schunter M, Stange EF, Tilg H, Van Assche G, Viget N, Vucelic B, Walsh A, Weiss G, Yazdanpanah Y, Zabana Y, Travis SP, Colombel JF. European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 2009; 3: 47-91 [PMID: 21172250 DOI: 10.1016/j.crohns.2009.02.010]
63. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99: 1371-1385 [PMID: 15233681 DOI: 10.1111/j.1572-0241.2004.40036.x]
64. Hommes DW, Sterringa G, Boom R. Incidence and outcome of cytomegalovirus infection in patients with inflammatory bowel disease. Gastroenterology 2002; 122: A1287
65. D'Ovidio V, Vernia P, Gentile G, Capobianchi A, Marcheggiano A, Viscido A, Martino P, Caprilli R. Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol 2008; 43: 180-183 [PMID: 18614396 DOI: 10.1016/j.jcv.2008.06.002]
66. Orvar K, Murray J, Carmen G, Conklin J. Cytomegalovirus infection associated with onset of inflammatory bowel disease. Dig Dis Sci 1993; 38: 2307-2310 [PMID: 8261839 DOI: 10.1007/BF01299914]
67. Knösel T, Schewe C, Petersen N, Dietel M, Petersen I. Prevalence of infectious pathogens in Crohn's disease. Pathol Res Pract 2009; 205: 223-230 [PMID: 19186006 DOI: 10.1016/j.prp.2008.04.018]
68. Takahashi Y, Tange T. Prevalence of cytomegalovirus infection in inflammatory bowel disease patients. Dis Colon Rectum 2004; 47: 722-726 [PMID: 15037934 DOI: 10.1007/s10350-003-0117-3]
69. Kaufman HS, Kahn AC, Iacobuzio-Donahue C, Talamini MA, Lillemoe KD, Hamilton SR. Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum 1999; 42: 24-30 [PMID: 10211516 DOI: 10.1007/BF02235178]
70. Nakase H, Yoshino T, Honzawa Y, Chiba T. Low prevalence of CMV infection in patients with Crohn's disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Dig Dis Sci 2010; 55: 1498-1499 [PMID: 20198427 DOI: 10.1007/s10620-010-1162-0]
71. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157: 1261-1270 [PMID: 8757634]
72. Kojima T, Watanabe T, Hata K, Shinozaki M, Yokoyama T, Nagawa H. Cytomegalovirus infection in ulcerative colitis. Scand J Gastroenterol 2006; 41: 706-711 [PMID: 16716970 DOI: 10.1080/00365520500408584]
73. Kishore J, Ghoshal U, Ghoshal UC, Krishnani N, Kumar S, Singh M, Ayyagari A. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 2004; 53: 1155-1160 [PMID: 15496396 DOI: 10.1099/jmm.0.45629-0]
74. Vega R, Bertrán X, Menacho M, Domènech E, Moreno de Vega V, Hombrados M, Cabré E, Ojanguren I, Gassull MA. Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1053-1056 [PMID: 10201482 DOI: 10.1016/S0002-9270(99)00068-4]
75. Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001; 96: 2137-2142 [PMID: 11467645 DOI: 10.1016/S0002-9270(01)02512-6]
76. Kambham N, Vij R, Cartwright CA, Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol 2004; 28: 365-373 [PMID: 15104299 DOI: 10.1097/00000478-200403000-00009]
77. Maconi G, Colombo E, Zerbi P, Sampietro GM, Fociani P, Bosani M, Cassinotti A, Casini V, Russo A, Ardizzone S, Porta M, Bianchi Porro G. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 2005; 37: 418-423 [PMID: 15893280 DOI: 10.1016/j.dld.2005.01.011]
78. Pofelski J, Heluwaert F, Roblin X, Morand P, Gratacap B, Germain E, Brion JP, Salon C, Bonaz B. Cytomegalovirus and cryptogenic inflammatory bowel disease. Gastroenterol Clin Biol 2007; 31: 292-296 [PMID: 17396088 DOI: GCB-03-20 07-31-3-0399-8320-101019-200520007]
79. Mendez JC, Espy MJ, Smith TF, Wilson JA, Paya CV. Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver transplantation. J Clin Microbiol 1998; 36: 526-530 [PMID: 9466770 DOI: 0095-1137/98/$04.0010]
80. Eyre-Brook IA, Dundas S. Incidence and clinical significance of colonic cytomegalovirus infection in idiopathic inflammatory bowel disease requiring colectomy. Gut 1986; 27: 1419-1425 [PMID: 3026932 DOI: 10.1136/gut.27.12.1419]
81. Cooper HS, Raffensperger EC, Jonas L, Fitts WT. Cytomegalovirus inclusions in patients with ulcerative colitis and toxic dilation requiring colonic resection. Gastroenterology 1977; 72: 1253-1256 [PMID: 192627]
82. Alcalá MJ, Casellas F, Pallarés J, de Torres I, Malagelada JR. Infection by cytomegalovirus in patients with ulcerative colitis requiring colonic resection. Med Clin (Barc) 2000; 114: 201-204 [PMID: 10757099]
83. Targan SR, Karp LC. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev 2005; 206: 296-305 [PMID: 16048556 DOI: 10.1111/j.0105-2896.2005.00286.x]
84. Ginsburg CH, Dambrauskas JT, Ault KA, Falchuk ZM. Impaired natural killer cell activity in patients with inflammatory bowel disease: evidence for a qualitative defect. Gastroenterology 1983; 85: 846-851 [PMID: 6884709]
85. de Saussure P, Lavergne-Slove A, Mazeron MC, Alain S, Matuchansky C, Bouhnik Y. A prospective assessment of cytomegalovirus infection in active inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20: 1323-1327 [PMID:15606394 DOI: 10.1111/j.1365-2036.2004.02273.x]
86. Widmann T, Sester U, Gärtner BC, Schubert J, Pfreundschuh M, Köhler H, Sester M. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation. PLoS One 2008; 3: e3634 [PMID: 18982061 DOI: 10.1371/journal.pone.0003634]
87. Forbes BA, Bonville CA, Dock NL. The effects of a promoter of cell differentiation and selected hormones on human cytomegalovirus infection using an in vitro cell system. J Infect Dis 1990; 162: 39-45 [PMID: 1693943 DOI: 10.1093/infdis/162.1.39]
88. Lavagna A, Bergallo M, Daperno M, Sostegni R, Costa C, Leto R, Crocellà L, Molinaro G, Rocca R, Cavallo R, Pera A. Infliximab and the risk of latent viruses reactivation in active Crohn's disease. Inflamm Bowel Dis 2007; 13: 896-902 [PMID: 17345605 DOI: 10.1002/ibd.20131]
89. Adler SP, Hempfling SH, Starr SE, Plotkin SA, Riddell S. Safety and immunogenicity of the Towne strain cytomegalovirus vaccine. Pediatr Infect Dis J 1998; 17: 200-206 [PMID: 9535246 DOI: 10.1097/00006454-199803000-00006]
90. Nakase H, Yamamoto S, Matsuura M, Honzawa Y, Chiba T. Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimus. Aliment Pharmacol Ther 2010; 32: 510-511 [PMID: 20636704 DOI: 10.1111/j.1365-2036.2010.04372.x]
91. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci USA 1998; 95: 3937-3942 [PMID: 9520471 DOI: 10.1073/pnas.95.7.3937]
92. Söderberg-Nauclér C, Fish KN, Nelson JA. Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest 1997; 100: 3154-3163 [PMID: 9399963 DOI: 10.1172/JCI119871]
93. Simon CO, Seckert CK, Dreis D, Reddehase MJ, Grzimek NK. Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol 2005; 79: 326-340 [PMID: 15596827 DOI:10.1128/JVI.79.1.326-340.2005]
94. Hommes DW, Sterringa G, van Deventer SJ, Tytgat GN, Weel J. The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 2004; 10: 245-250 [PMID: 15290919 DOI: 10.1097/00054725-2 00405000-00011]
95. Söderberg-Nauclér C, Nelson JY. Human cytomegalovirus latency and reactivation-a delicate balance between the virus and its host's immune system. Intervirology 1999; 42: 314-321 [PMID: 10702712]
96. Nakase H, Yoshino T, Matumura K, Honzawa Y, Yamamoto S, Matsuura M, Chiba T. Positive finding of colonic polymerase chain reaction for cytomegalovirus DNA is not false positive but a warning for treating patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2011; 17: E13-E14 [PMID: 20629104 DOI: 10.1002/ibd.21401]
97. Diepersloot RJ, Kroes AC, Visser W, Jiwa NM, Rothbarth PH. Acute ulcerative proctocolitis associated with primary cytomegalovirus infection. Arch Intern Med 1990; 150: 1749-1751 [PMID: 2166491 DOI: 10.1001/archinte.150.8.1749]
98. Rachima C, Maoz E, Apter S, Thaler M, Grossman E, Rosenthal T. Cytomegalovirus infection associated with ulcerative colitis in immunocompetent individuals. Postgrad Med J 1998; 74: 486-489 [PMID: 9926125 DOI: 10.1136/pgmj.74.874.486]
99. Streetz KL, Buhr T, Wedemeyer H, Bleck J, Schedel I, Manns MP, Göke MN. Acute CMV-colitis in a patient with a history of ulcerative colitis. Scand J Gastroenterol 2003; 38: 119-122 [PMID: 12608474 DOI: 10.1080/00365520310000546]
100. Helbling D, Breitbach TH, Krause M. Disseminated cytomegalovirus infection in Crohn's disease following antitumour necrosis factor therapy. Eur J Gastroenterol Hepatol 2002; 14: 1393-1395 [PMID: 12468964 DOI: 10.1097/00042737-200212000-00018]
101. Farmer GW, Vincent MM, Fuccillo DA, Horta-Barbosa L, Ritman S, Sever JL, Gitnick GL. Viral investigations in ulcerative colitis and regional enteritis. Gastroenterology 1973; 65: 8-18 [PMID: 4352745]
102. Minami M, Ohta M, Ohkura T, Ando T, Ohmiya N, Niwa Y, Goto H. Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan. World J Gastroenterol 2007; 13: 754-760 [PMID: 17278199]
103. Goodrich J, Khardori N. Cytomegalovirus: the taming of the beast? Lancet 1997; 350: 1718-1719 [PMID: 9413457 DOI: 10.1016/S0140-6736(97)22050-7]
104. Omiya M, Matsushita M, Tanaka T, Kawamata S, Okazaki K.The absence of large ulcer predicts latent cytomegalovirusinfection in ulcerative colitis with positive mucosal viral assay. Intern Med 2010; 49: 2277-2282 [PMID: 21048360 DOI: 10.2169/internalmedicine.49.3657]
105. Faulds D, Heel RC. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs 1990; 39: 597-638 [PMID: 2161731 DOI: 10.2165/00003495-199039040-00008]
106. Markham A, Faulds D. Ganciclovir. An update of its therapeutic use in cytomegalovirus infection. Drugs 1994; 48: 455-484 [PMID: 7527763 DOI: 10.2165/00003495-199448030-00009]
107. Heuman DM. Cytomegalovirus colitis. Available from: URL: http://emedicine.medscape.com/article/173151-overview
108. Eddleston M, Peacock S, Juniper M, Warrell DA. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 1997; 24: 52-56 [PMID: 8994755 DOI: 10.1093/clinids/ 24.1.52]